eComment: Re: Do we need fenestration when performing two-staged total cavopulmonary connection using an extracardiac conduit?
Bockeria
Leo A
LA
Bakoulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Movsesian
Ruben R
RR
D000280:Administration, Inhalation; D000284:Administration, Oral; D002315:Cardiopulmonary Bypass; D003131:Combined Modality Therapy; D018729:Fontan Procedure / Q000009:adverse effects / Q000401:mortality; D018610:Heart Bypass, Right / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D006330:Heart Defects, Congenital / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D006439:Hemodynamics; D006801:Humans; D007275:Injections, Intravenous; D009569:Nitric Oxide / Q000008:administration & dosage; D010102:Oxygen Inhalation Therapy; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D011651:Pulmonary Artery / Q000187:drug effects / Q000503:physiopathology / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage
D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011138:Polytetrafluoroethylene